119 related articles for article (PubMed ID: 14744091)
21. Patterns of recurrence after sentinel lymph node biopsy for cutaneous melanoma.
Fincher TR; McCarty TM; Fisher TL; Preskitt JT; Lieberman ZH; Stephens JF; O'Brien JC; Kuhn JA
Am J Surg; 2003 Dec; 186(6):675-81. PubMed ID: 14672778
[TBL] [Abstract][Full Text] [Related]
22. Total sentinel lymph node tumor size predicts nonsentinel node metastasis and survival in patients with melanoma.
Cadili A; Scolyer RA; Brown PT; Dabbs K; Thompson JF
Ann Surg Oncol; 2010 Nov; 17(11):3015-20. PubMed ID: 20552405
[TBL] [Abstract][Full Text] [Related]
23. Malignant melanoma in an 8-year-old Caribbean girl: diagnostic criteria and utility of sentinel lymph node biopsy.
Durrani AJ; Moir GC; Diaz-Cano SJ; Cerio R
Br J Dermatol; 2003 Mar; 148(3):569-72. PubMed ID: 12653752
[TBL] [Abstract][Full Text] [Related]
24. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma.
Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B
J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant therapy of malignant melanoma and the role of sentinel node mapping.
Eggermont AM
Recent Results Cancer Res; 2000; 157():178-89. PubMed ID: 10857171
[TBL] [Abstract][Full Text] [Related]
26. Association of sentinel lymph node diameter with melanoma metastasis.
Merkow J; Paniccia A; Jones E; Jones T; Hodges M; Stovall R; Kounalakis N; Gajdos C; Lewis K; Robinson W; Gonzalez R; Pearlman N; McCarter M
Am J Surg; 2016 Aug; 212(2):315-20. PubMed ID: 26827186
[TBL] [Abstract][Full Text] [Related]
27. Survival analysis and clinicopathological factors associated with false-negative sentinel lymph node biopsy findings in patients with cutaneous melanoma.
Nowecki ZI; Rutkowski P; Nasierowska-Guttmejer A; Ruka W
Ann Surg Oncol; 2006 Dec; 13(12):1655-63. PubMed ID: 17016755
[TBL] [Abstract][Full Text] [Related]
28. Pathology of Melanoma.
Chopra A; Sharma R; Rao UNM
Surg Clin North Am; 2020 Feb; 100(1):43-59. PubMed ID: 31753115
[TBL] [Abstract][Full Text] [Related]
29. Sentinel lymph node biopsy in melanoma: a micromorphometric study relating to prognosis and completion lymph node dissection.
Debarbieux S; Duru G; Dalle S; Béatrix O; Balme B; Thomas L
Br J Dermatol; 2007 Jul; 157(1):58-67. PubMed ID: 17501957
[TBL] [Abstract][Full Text] [Related]
30. Characterization of micrometastatic disease in melanoma sentinel lymph nodes by enhanced pathology: recommendations for standardizing pathologic analysis.
Spanknebel K; Coit DG; Bieligk SC; Gonen M; Rosai J; Klimstra DS
Am J Surg Pathol; 2005 Mar; 29(3):305-17. PubMed ID: 15725798
[TBL] [Abstract][Full Text] [Related]
31. Sentinel lymph node biopsy for patients with problematic spitzoid melanocytic lesions: a report on 18 patients.
Su LD; Fullen DR; Sondak VK; Johnson TM; Lowe L
Cancer; 2003 Jan; 97(2):499-507. PubMed ID: 12518375
[TBL] [Abstract][Full Text] [Related]
32. Deep penetrating nevus-like borderline tumors: A unique subset of ambiguous melanocytic tumors with malignant potential and normal cytogenetics.
Magro CM; Abraham RM; Guo R; Li S; Wang X; Proper S; Crowson AN; Mihm M
Eur J Dermatol; 2014; 24(5):594-602. PubMed ID: 25118781
[TBL] [Abstract][Full Text] [Related]
33. Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma.
Gershenwald JE; Colome MI; Lee JE; Mansfield PF; Tseng C; Lee JJ; Balch CM; Ross MI
J Clin Oncol; 1998 Jun; 16(6):2253-60. PubMed ID: 9626228
[TBL] [Abstract][Full Text] [Related]
34. The long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple technique.
Rutkowski P; Szydłowski K; Nowecki ZI; Sałamacha M; Goryń T; Mitręga-Korab B; Pieńkowski A; Dziewirski W; Zdzienicki M
World J Surg Oncol; 2015 Oct; 13():299. PubMed ID: 26462471
[TBL] [Abstract][Full Text] [Related]
35. Predictors of nonsentinel lymph node positivity in patients with a positive sentinel node for melanoma.
Sabel MS; Griffith K; Sondak VK; Lowe L; Schwartz JL; Cimmino VM; Chang AE; Rees RS; Bradford CR; Johnson TM
J Am Coll Surg; 2005 Jul; 201(1):37-47. PubMed ID: 15978442
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic utility of dual 5-hydroxymethylcytosine/Melan-A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first-line test for the workup of sentinel lymph node specimen.
Siref AB; Huynh CAT; Balzer BL; Frishberg DP; Essner R; Shon W
J Cutan Pathol; 2019 Apr; 46(4):261-266. PubMed ID: 30632191
[TBL] [Abstract][Full Text] [Related]
37. Nevoid melanoma.
Diwan AH; Lazar AJ
Clin Lab Med; 2011 Jun; 31(2):243-53. PubMed ID: 21549238
[TBL] [Abstract][Full Text] [Related]
38. Lymphatic flow is mostly preserved after sentinel lymph node biopsy in primary cutaneous malignant melanoma.
Yokota K; Sawada M; Matsumoto T; Hasegawa Y; Kono M; Akiyama M
J Dermatol Sci; 2015 May; 78(2):101-7. PubMed ID: 25771166
[TBL] [Abstract][Full Text] [Related]
39. Pathologic review of negative sentinel lymph nodes in melanoma patients with regional recurrence: a clinicopathologic study of 1152 patients undergoing sentinel lymph node biopsy.
Li LX; Scolyer RA; Ka VS; McKinnon JG; Shaw HM; McCarthy SW; Thompson JF
Am J Surg Pathol; 2003 Sep; 27(9):1197-202. PubMed ID: 12960803
[TBL] [Abstract][Full Text] [Related]
40. Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma.
Wagner JD; Gordon MS; Chuang TY; Coleman JJ; Hayes JT; Jung SH; Love C
Cancer; 2000 Jul; 89(2):453-62. PubMed ID: 10918179
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]